Authors: ZACHARIAE H ABRAMS B BLEEHEN SS BRAUTIGAM M BURROWS D ETTELT MJ FRY L HAPPLE R HAUSTEIN UF GANSLANDT J JUNG EG KNOP J KUHNE KH MELLEIN B MORK NJ ROGERS S SCHMIDT AG SCHOPF RE SUMNER M TAUBE KM WEIDINGER G WURDEL C ZAHN E

Citation: H. Zachariae et al., CONVERSION OF PSORIASIS PATIENTS FROM THE CONVENTIONAL FORMULATION OFCYCLOSPORINE-A TO A NEW MICROEMULSION FORMULATION - A RANDOMIZED, OPEN, MULTICENTER ASSESSMENT OF SAFETY AND TOLERABILITY, Dermatology, 196(2), 1998, pp. 231-236

Authors: TAUSCH I BRAUTIGAM M WEIDINGER G JONES TC TAUSCH I BOHM K SCHMIDT U WESTPHAL HJ WURDEL C SCHOPF R ROSINUS A SCHAFER B JUNG FG SCHELL E SCHWEISS D HAPPLE R SCHOPF E FALKNER G ALTMEYER P MENSING H BORELLI S ENGST R PAETZOLD FW BERNS W MARGHESCU S FRITZ F SCHERWITZ C GOOS M BRINKMANN C KHAMSSI M HANEKE E LACOUR T BRAUTIGAM M WEIDINGER G PETRY G TANKE R HEINRICH H GEISLER U

Citation: I. Tausch et al., EVALUATION OF 6 WEEKS TREATMENT OF TERBINAFINE IN TINEA UNGUIUM IN A DOUBLE-BLIND TRIAL COMPARING 6 AND 12 WEEKS THERAPY, British journal of dermatology, 136(5), 1997, pp. 737-742